Your browser doesn't support javascript.
loading
EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling.
Randzavola, Lyra O; Mortimer, Paige M; Garside, Emma; Dufficy, Elizabeth R; Schejtman, Andrea; Roumelioti, Georgia; Yu, Lu; Pardo, Mercedes; Spirohn, Kerstin; Tolley, Charlotte; Brandt, Cordelia; Harcourt, Katherine; Nichols, Esme; Nahorski, Mike; Woods, Geoff; Williamson, James C; Suresh, Shreehari; Sowerby, John M; Matsumoto, Misaki; Santos, Celio X C; Kiar, Cher Shen; Mukhopadhyay, Subhankar; Rae, William M; Dougan, Gordon J; Grainger, John; Lehner, Paul J; Calderwood, Michael A; Choudhary, Jyoti; Clare, Simon; Speak, Anneliese; Santilli, Giorgia; Bateman, Alex; Smith, Kenneth G C; Magnani, Francesca; Thomas, David C.
Affiliation
  • Randzavola LO; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom.
  • Mortimer PM; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom.
  • Garside E; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom.
  • Dufficy ER; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Schejtman A; Molecular Immunology Unit, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Roumelioti G; Functional Proteomics, Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom.
  • Yu L; Functional Proteomics, Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom.
  • Pardo M; Functional Proteomics, Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom.
  • Spirohn K; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, United States.
  • Tolley C; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States.
  • Brandt C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States.
  • Harcourt K; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Nichols E; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Nahorski M; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
  • Woods G; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom.
  • Williamson JC; Cambridge Institute of Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Suresh S; Cambridge Institute of Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Sowerby JM; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Matsumoto M; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Santos CXC; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Kiar CS; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Mukhopadhyay S; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Rae WM; Department of Pharmacology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Dougan GJ; School of Cardiovascular Medicine and Sciences, James Black Centre, King's College London, London, United Kingdom.
  • Grainger J; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
  • Lehner PJ; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
  • Calderwood MA; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Choudhary J; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Clare S; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Speak A; Functional Proteomics, Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom.
  • Santilli G; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
  • Bateman A; The Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Magnani F; Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, United States.
  • Thomas DC; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, United States.
Elife ; 112022 11 24.
Article in En | MEDLINE | ID: mdl-36421765
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NADPH Oxidases / Granulomatous Disease, Chronic Limits: Animals / Humans Language: En Journal: Elife Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: NADPH Oxidases / Granulomatous Disease, Chronic Limits: Animals / Humans Language: En Journal: Elife Year: 2022 Document type: Article Affiliation country: Country of publication: